The risk factors potentially influencing risk of serious illness/death in people with diabetes, following SARS-CoV-2 infection: What needs to be done from here.

Abstract

Adrian H. Heald, Mark Livingston, Gabriela Moreno and John Martin Gibson, The School of Medicine and Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, Department of Clinical Biochemistry, Black Country Pathology Services, Walsall Manor Hospital, Walsall, UK and Coordinación Nacional de Investigación, Subdirección de Servicios de Salud, Petróleos Mexicanos, Ciudad de México, México